Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

INNV Stock Annual Income Statement. Download in Excel

Innovus Pharms Inc logo

Innovus Pharms Inc

Sector: Healthcare   

Industry: Drug Manufacturers - Major

5.94
 
USD
  
0.01
  
(0.17%)
Previous close: 5.93  Open: 5.87  Bid: 4.52  Ask: 6.5
52 week range    
3.52   
   6.71
Mkt Cap: 738 M  Avg Vol (90 Days): 46,947
Peers   
HZNP / 
ACRX / 
MRK / 
Last updated: Tuesday 15th October 2024

Stock Rankings

53
MarketXLS Rank
40
Value
69
Technical
50
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Financials

INNV Income Statement

Annual
Invalid dateJun-21Jun-22Jun-23
AccretionOnPreferredStock17 M
Amortization of intangibles124 M124 M124 M
Basic EPS from continuing operations-0.36-0.05-0.3
Basic EPS total-0.36-0.05-0.3
Basic weighted shares outstanding124 M136 M136 M
Cost of sales-155 M563 M212 M
Depreciation12 M14 M15 M
Depreciation unreconciled12 M14 M15 M
DepreciationAndAmortization12 M14 M15 M
Diluted EPS total-0.36-0.05-0.3
Diluted normalized net income/share-0.36-0.05-0.3
Diluted weighted shares outstanding124 M136 M136 M
Earnings from equity interest10 M
EarningsFromEquityInterestNetOfTax10 M
GeneralAndAdministrativeExpense132 M102 M116 M
Gross operating profit793 M135 M476 M
Income before tax584 M-7 M324 M
Income restructuring and M&A-2 M
Income taxes10 M723000.0-7 M
Interest income-3 M-2 M
InterestExpenseNonOperating17 M3 M2 M
MinorityInterests754000.01 M3 M
MiscOtherSpecialCharges-17 M-305000.0124000.0
Net income from total operations-44 M-7 M-41 M
NetIncomeCommonStockholders575 M-7 M-41 M
NetIncomeContinuousOperations-44 M-8 M-44 M
NetNonOperatingInterestIncomeExpense-17 M-3 M-2 M
Operating income-12 M-4 M-49 M
Operating income before depreciation (EBITDA)614 M10 M-35 M
OperatingExpense185 M140 M151 M
Other income net7 M-305000.0-124000.0
OtherGandA132 M102 M116 M
OtherOperatingExpenses18 M9 M
OtherunderPreferredStockDividend17 M
PreferredStockDividends17 M
PromotionAndAdvertising7 M7 M6 M
RentAndLandingFees5 M5 M
RestructringAndMnAIncome-2 M
Revenue per share125 M124 M124 M
Selling Gen & administrative expense155 M126 M135 M
SellingAndMarketingExpense22 M24 M20 M
Special income/charges2 M
Total Income available for interest expense (EBIT)600 M-5 M-51 M
Total common shares outstanding136 M136 M136 M
Total net income-44 M-7 M-41 M
Total ordinary shares136 M136 M136 M
Total revenues638 M699 M688 M
TotalExpenses30 M703 M363 M
TotalRevenue638 M699 M688 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University